An evaluation of cyclooxygenase-1 inhibition before coronary artery surgery: Aggregometry versus patient self-reporting

Anesthesia and Analgesia

Volumn 107, Issue 6, 2008, Pages 1791-1797

  Rahe Meyer, Niels ^a   Winterhalter, Michael ^a   Hartmann, Julia ^a   Pattison, Albert ^b   Hecker, Hartmut ^a   Calatzis, Andreas ^c   Solomon, Cristina ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b Hart Biologicals   (United Kingdom)

^c LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; APROTININ; ARACHIDONIC ACID; CYCLOOXYGENASE 1; HEPARIN; PROTAMINE SULFATE; PROSTAGLANDIN SYNTHASE INHIBITOR;

ADULT; AGED; ANTICOAGULANT THERAPY; ARTICLE; BLOOD CLOTTING DISORDER; CELL ASSAY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; DRAIN; DRUG UTILIZATION; ENZYME INHIBITION; ERYTHROCYTE TRANSFUSION; FEMALE; HUMAN; HUMAN CELL; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROTEIN DETERMINATION; QUESTIONNAIRE; SELF REPORT; THROMBOCYTE AGGREGATION; THROMBOCYTE TRANSFUSION; TREATMENT DURATION; COMPARATIVE STUDY; DRUG EFFECT; MIDDLE AGED; PROSPECTIVE STUDY;

ADULT; AGED; AGED, 80 AND OVER; ARACHIDONIC ACID; ASPIRIN; CORONARY ARTERY BYPASS; CYCLOOXYGENASE 1; CYCLOOXYGENASE INHIBITORS; ERYTHROCYTE TRANSFUSION; FEMALE; HUMANS; MALE; MIDDLE AGED; PLATELET AGGREGATION; PROSPECTIVE STUDIES;

EID: 58149291642     PISSN: 00032999     EISSN: None     Source Type: Journal    
DOI: 10.1213/ane.0b013e3181865733     Document Type: Article

References (26)

1. Cattaneo M. Aspirin and clopidogrel: efficacy, safety, and the issue of drug resistance. Arterioscler Thromb Vasc Biol 2004;24:1980-7
2. Harder S, Klinkhardt U, Alvarez JM. Avoidance of bleeding during surgery in patients receiving anticoagulant and/or antiplatelet therapy: pharmacokinetic and pharmacodynamic considerations. Clin Pharmacokinet 2004;43:963-81
3. Hekmat K, Menzel C, Kroener A, Schwinger RH, Kampe S, Fischer UM, Geissler HJ, Mehlhorn U. The effect of preoperative antiplatelet therapy in coronary artery surgery: blood transfusion requirements for patients on cardiopulmonary bypass. Curr Med Res Opin 2004;20:1429-35
4. Reich DL, Patel GC, Vela-Cantos F, Bodian C, Lansman S. Aspirin does not increase homologous blood requirements in elective coronary bypass surgery. Anesth Analg 1994;79:4-8
5. Gibbs NM, Weightman WM, Thackray NM, Michalopoulos N, Weidmann C. The effects of recent aspirin ingestion on platelet function in cardiac surgical patients. J Cardiothorac Vasc Anesth 2001;15:55-9
6. Bybee KA, Powell BD, Valeti U, Rosales AG, Kopecky SL, Mullany C, Wright RS. Preoperative aspirin therapy is associated with improved postoperative outcomes in patients undergoing coronary artery bypass grafting. Circulation 2005;112(9 Suppl):I286 -I292
7. Tuman KJ, McCarthy RJ, O'Connor CJ, McCarthy WE, Ivankovich AD. Aspirin does not increase allogenic blood transfusion in reoperative coronary artery surgery. Anesth Analg 1996; 83:1178-84
8. Cardinal DC, Flower RJ. The electronic aggregometer: a novel device for assessing platelet behavior in blood. J Pharmacol Methods 1980;3:135-58
9. Nicholson NS, Panzer-Knodle SG, Haas NF, Taite BB, Szalony JA, Page JD, Feigen LP, Lansky DM, Salyers AK. Assessment of platelet function assays. Am Heart J 1998;135:S170-S178
10. To' th O, Calatzis A, Penz S, Losonczy H, Siess W. Multiple electrode aggregometry: a new device to measure platelet aggregation in whole blood. Thromb Haemost 2006;96:781-8
11. Mueller T, Dieplinger B, Poelz W, Calatzis A, Haltmayer M. Utility of whole blood impedance aggregometry for the assessment of clopidogrel action using the novel Multiplate(R) analyzer-comparison with two flow cytometric methods. Thromb Res 2007;121:249-58
12. Scharbert G, Gebhardt K, Sow Z, Duris M, Deusch E, Kozek- Langenecker S. Point-of-care platelet function tests: detection of platelet inhibition induced by nonopioid analgesic drugs. Blood Coagul Fibrinolysis 2007;18:775-80
13. Hovens MM, Snoep JD, Eikenboom JC, van der Bom JG, Mertens BJ, Huisman MV. Prevalence of persistent platelet reactivity despite use of aspirin: a systematic review. Am Heart J 2007;153:175-81
14. Ray MJ, Hawson GA, Just SJ, McLachlan G, O'Brien M. Relationship of platelet aggregation to bleeding after cardiopulmonary bypass. Ann Thorac Surg 1994;57:981-6
15. Schlichter SJ. Platelet transfusion therapy. Hematol Oncol Clin North Am 2007;21:697-729
16. Born GV, Cross MJ. The aggregation of blood platelets. J Physiol 1963;168:178-95
17. Reiss RF, Katz AJ. Microaggregate content and flow rates of packed red blood cells. Transfusion 1977;17:484-9
18. Santos MT, Valle's J, Aznar J, Lago A, Sanchez E, Cosin J, Moscardo' A, Piño'n M, Broekman MJ, Marcus AJ. Aspirin therapy for inhibition of platelet reactivity in the presence of erythrocytes in patients with vascular disease. J Lab Clin Med 2006;147:220-7
19. Breddin HK. Can platelet aggregometry be standardized? Platelets 2005;16:151-8
20. Sathiropas P, Marbet GA, Sahaphong S, Duckert F. Detection of small inhibitory effects of acetylsalicylic acid (ASA) by platelet impedance aggregometry in whole blood. Thromb Res 1988;51:55-62
21. Chakroun T, Gerotziafas G, Robert F, Lecrubier C, Samama MM, Hatmi M, Elalamy I. In vitro aspirin resistance detected by PFA-100 closure time: pivotal role of plasma von Willebrand factor. Br J Haematol 2004;124:80-5
22. Cammerer U, Dietrich W, Rampf T, Braun SL, Richter JA. The predictive value of modified computerized thromboelastography and platelet function analysis for postoperative blood loss in routine cardiac surgery. Anesth Analg 2003;96:51-7
23. Dyszkiewicz-Korpanty AM, Kim A, Burner JD, Frenkel EP, Sarode R. Comparison of a rapid platelet function assay-Verify Now Aspirin-with whole blood impedance aggregometry for the detection of aspirin resistance. Thromb Res 2007;120:485-8
24. Lordkipanidze' M, Pharand C, Schampaert E, Turgeon J, Palisaitis DA, Diodati JG. A comparison of six major platelet function tests to determine the prevalence of aspirin resistance in patients with stable coronary artery disease. Eur Heart J 2007;28:1702- 8
25. Wallen NH, Ladjevardi M, Albert J, Broijersen A. Influence of different anticoagulants on platelet aggregation in whole blood; a comparison between citrate, low molecular mass heparin and hirudin. Thromb Res 1997;87:151-7
26. Belcher PR, Muriithi EW, Milne EM, Vanikiat P, Wheatley DJ, Armstrong RA. Heparin, platelet aggregation, neutrophils, and cardiopulmonary bypass. Thromb Res 2000;98:249 -56